DK330378A - Fremgangsmaade til fremstilling af terapeutisk aktive 6,7-dihydro-5h, 13h-chinazolino (3,2-a)-(1,4) benzodiazepin-5,13-dioner - Google Patents

Fremgangsmaade til fremstilling af terapeutisk aktive 6,7-dihydro-5h, 13h-chinazolino (3,2-a)-(1,4) benzodiazepin-5,13-dioner

Info

Publication number
DK330378A
DK330378A DK330378A DK330378A DK330378A DK 330378 A DK330378 A DK 330378A DK 330378 A DK330378 A DK 330378A DK 330378 A DK330378 A DK 330378A DK 330378 A DK330378 A DK 330378A
Authority
DK
Denmark
Prior art keywords
chinazolino
dioner
benzodiazepine
dihydro
procedure
Prior art date
Application number
DK330378A
Other languages
English (en)
Inventor
K H Mayer
H Heitzer
F Hoffmeister
A Heise
S Kazda
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772733681 external-priority patent/DE2733681A1/de
Priority claimed from DE19772758875 external-priority patent/DE2758875A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK330378A publication Critical patent/DK330378A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK330378A 1977-07-26 1978-07-25 Fremgangsmaade til fremstilling af terapeutisk aktive 6,7-dihydro-5h, 13h-chinazolino (3,2-a)-(1,4) benzodiazepin-5,13-dioner DK330378A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772733681 DE2733681A1 (de) 1977-07-26 1977-07-26 6,7-dihydro-5h, 13h-chinazolino eckige klammer auf 3,2-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-5,13-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19772758875 DE2758875A1 (de) 1977-12-30 1977-12-30 6,7-dihydro-5h,13h-chinazolino eckige klammer auf 3,2-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-5,13-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DK330378A true DK330378A (da) 1979-01-27

Family

ID=25772398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK330378A DK330378A (da) 1977-07-26 1978-07-25 Fremgangsmaade til fremstilling af terapeutisk aktive 6,7-dihydro-5h, 13h-chinazolino (3,2-a)-(1,4) benzodiazepin-5,13-dioner

Country Status (9)

Country Link
US (1) US4187306A (da)
EP (1) EP0000538A1 (da)
JP (1) JPS5424896A (da)
AU (1) AU3828478A (da)
DK (1) DK330378A (da)
ES (1) ES471985A1 (da)
FI (1) FI782318A (da)
IL (1) IL55207A0 (da)
IT (1) IT7826042A0 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530790A (en) * 1982-12-27 1985-07-23 Merck & Co., Inc. Cholecystokinin antagonists
US4559338A (en) * 1985-01-25 1985-12-17 Merck & Co., Inc. Soluble quinazolino-1,4-benzodiazepin-5,13-dione derivatives
US4563451A (en) * 1985-01-25 1986-01-07 Merck & Co., Inc. Quinazolino-1,4-benzodiazepin-5,13-diones
US4554272A (en) * 1985-01-25 1985-11-19 Merck & Co., Inc. Substituted quinazolino-1,4-benzodiazepin-6,9-diones and their preparation
EP0272868A1 (en) * 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 6-membered heterocyclic rings
US4735941A (en) * 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
US5670640A (en) * 1996-02-02 1997-09-23 Hoffmann-La Roche Inc. Process for the manufacture of imidazodiazepine derivatives
AR112788A1 (es) 2017-09-07 2019-12-11 Eisai R&D Man Co Ltd Compuesto pentacíclico
JP7504864B2 (ja) * 2019-03-05 2024-06-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 五環式複素環化合物
AU2020233452A1 (en) * 2019-03-05 2021-09-02 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystals thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3280117A (en) * 1964-04-20 1966-10-18 Sandoz Ag Tricyclic quinazolinones
US3651046A (en) * 1969-01-30 1972-03-21 Hoffmann La Roche Quinazolino-benzodiazepines and methods for the preparation thereof

Also Published As

Publication number Publication date
IT7826042A0 (it) 1978-07-24
ES471985A1 (es) 1979-10-01
EP0000538A1 (de) 1979-02-07
JPS5424896A (en) 1979-02-24
IL55207A0 (en) 1978-09-29
AU3828478A (en) 1980-01-31
US4187306A (en) 1980-02-05
FI782318A (fi) 1979-01-27

Similar Documents

Publication Publication Date Title
DK13878A (da) Fremgangsmaade til fremstilling af 11beta-substituerede 4,9-diensteroider
DK148751C (da) Fremgangsmaade til fremstilling af cyclosporinderivater
DK110778A (da) Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK306978A (da) Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner
DK553978A (da) Fremgangsmaade til fremstilling af detoxificerede praeparater af cytostatika
DK13978A (da) Fremgangsmaade til fremstilling af 11betasubstituerede 1,3,5(,0)-triensteroider
DK330378A (da) Fremgangsmaade til fremstilling af terapeutisk aktive 6,7-dihydro-5h, 13h-chinazolino (3,2-a)-(1,4) benzodiazepin-5,13-dioner
DK145701C (da) Fremgangsmaade til fremstilling af ergotalkaloider
DK465578A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner
DK273776A (da) Fremgangsmade til fremstilling af 2,4-dioxo-1,2,3,4-tetrahydro-s-triazino-(1,2-a)-benzimidazoler
DK483378A (da) Fremgangsmaade til fremstilling af 2,4-difluoranilin
RO77485A (ro) Procedeu pentru prepararea 1,2,3-tiadiazol-3-in-5-ilidenureelor
DK237978A (da) Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
NO153137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte pyrido(1,2-a)pyrimidiner.
DK330178A (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK67978A (da) Fremgangsmaade til fremstilling af 1,3,5-triazin2,6-dioner
DK548478A (da) Fremgangsmaade til fremstilling af 2,4,5-trichlorphenol
DK221478A (da) Fremgangsmaade til fremstilling af alkaloider af leurosin-typen
NO781489L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
DK295378A (da) Fremgangsmaade til fremstilling af terapeutisk virksomme diarylalkylaminer
FI782517A (fi) Foerfarande foer framstaellning av 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)-pyrimidiner
IT1097328B (it) Procedimento per la preparazione di uretani aromatici
DK364578A (da) Fremgangsmaade til fremstilling af hydroxyphenylhydantoin
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK328478A (da) Fremgangsmaade til fremstilling af pyrrolo (2,1-b) (3) benzazepiner